Michael B. Paumen
Keine laufenden Positionen mehr
Profil
Michael B.
Paumen served as the Chief Executive Officer of Dx assays Pte Ltd.
He also held the position of Chief Executive Officer at Biolidics Ltd.
Prior to that, he worked as the Technical Director at Affymetrix, Inc. and as the Manager-Scientific Affairs at Qiagen, Inc. Paumen holds a doctorate degree from The Johannes Gutenberg University of Mainz.
Ehemalige bekannte Positionen von Michael B. Paumen
| Unternehmen | Position | Ende |
|---|---|---|
| BIOLIDICS LIMITED | Vorstandsvorsitzender | 23.03.2020 |
| AFFYMETRIX, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Qiagen, Inc.
 Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen, Inc. provided technologies for separating, purifying and handling nucleic acids. The company was founded in 1988 and was headquartered in Germantown, MD. | Technik-/Wissenschafts-/F&E-Leiter | - |
Dx assays Pte Ltd.
 Dx assays Pte Ltd. Medical SpecialtiesHealth Technology Established in 2008, Dx assays is Singapore's first commercial developer of molecular assays. Their company specializes in Nucleic Acid-based Test (NAT) development. They offer highly customizable services in assay design, development and validation for client-provided content in areas such as infectious disease testing, assay integration and development of companion diagnostic assays. Its laboratories are equipped with the state-of-the-art technologies and are operated by highly qualified personnel under the compliance of ISO-13485 : 2003. | Präsident | - |
Ausbildung von Michael B. Paumen
| The Johannes Gutenberg University of Mainz | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOLIDICS LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Dx assays Pte Ltd.
Dx assays Pte Ltd. Medical SpecialtiesHealth Technology Established in 2008, Dx assays is Singapore's first commercial developer of molecular assays. Their company specializes in Nucleic Acid-based Test (NAT) development. They offer highly customizable services in assay design, development and validation for client-provided content in areas such as infectious disease testing, assay integration and development of companion diagnostic assays. Its laboratories are equipped with the state-of-the-art technologies and are operated by highly qualified personnel under the compliance of ISO-13485 : 2003. | Health Technology |
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Qiagen, Inc.
Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen, Inc. provided technologies for separating, purifying and handling nucleic acids. The company was founded in 1988 and was headquartered in Germantown, MD. | Commercial Services |
